Dr. Jennifer Schneider
Schneider oversees product development, engineering and market growth for the digital health company. Under her leadership, Livongo's stock rose 40% and market cap peaked at over $4 billion during its initial public offering. She also led an expansion of the company's offerings by introducing innovative pairings with Amazon, including a HIPAA-compliant Alexa feature for blood glucose readings. And launched partnerships with Apple and other smartwatch developers.